A RELATIONSHIP BETWEEN ARTERIAL STIFFNESS, CYTOKINE LEVELS, AND BONE MINERAL DENSITY IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS

A RELATIONSHIP BETWEEN ARTERIAL STIFFNESS, CYTOKINE LEVELS, AND BONE MINERAL DENSITY IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS

Arterial stiffness is an independent predictor of cardiovascular diseases. A possible link between the development of osteoporosis (OP) and cardiovascular diseases is presently being considered. Cytokines that can affect the skeletal and cardiovascular systems act as pathogenetic factors of this int...

Full description

Bibliographic Details
Main Authors:	S. Yu. Tsarenok, V. V. Gorbunov, T. A. Aksenova
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2018-01-01
Series:	Научно-практическая ревматология
Subjects:	osteoporosis arterial stiffness cytokines
Online Access:	https://rsp.mediar-press.net/rsp/article/view/2468

Similar Items

The central aortic blood pressure and arterial stiffness during the daily monitoring procedure in postmenopausal women with osteoporosis
by: Svetlana Yu. Tsarenok, et al.
Published: (2017-12-01)

Associations of Arterial Stiffness and Bone Mineral Density in Postmenopausal Women
by: O. Yu. Isaykina, et al.
Published: (2023-03-01)

Arterial stiffness in postmenopausal women with arterial hypertension
by: O.М. Bilovol, et al.
Published: (2022-12-01)

The levels of osteoprotegerin, transforming growth factor-β, and some cytokines in women with coronary heart disease concurrent with severe osteoporosis
by: S Yu Tsarenok, et al.
Published: (2015-09-01)

The role of cytokines in bone remodeling and the pathogenesis of postmenopausal osteoporosis
by: G. A. Ignatenko, et al.
Published: (2020-06-01)

Pulse wave velocity and other indicators of arterial stiffness in hypertension comorbidity and chronic obstructive pulmonary disease
by: T A Aksenova, et al.
Published: (2018-03-01)

Aortic calcification, arterial stiffness and bone mineral density in patients with COPD☆
by: Charlotte E. Bolton, et al.
Published: (2011-02-01)

Association of cardiotrophin-like cytokine factor 1 levels in peripheral blood mononuclear cells with bone mineral density and osteoporosis in postmenopausal women
by: Xuan Chen, et al.
Published: (2021-01-01)

Relationship between bone mineral density and immune inflammatory parameters in women with osteoporosis concurrent with coronary heart diseases
by: S. Yu. Tsarenok, et al.
Published: (2014-09-01)

Association of Bone Mineral Density and Coronary Artery Calcification in Patients with Osteopenia and Osteoporosis
by: Tzyy-Ling Chuang, et al.
Published: (2020-09-01)

Metabolomics-based analysis of plasma in postmenopausal women with normal bone mineral density, postmenopausal osteoporosis, and rheumatoid arthritis osteoporosis
by: Kun Zhu, et al.
Published: (2023-12-01)

POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION
by: N. J. Hozjainova, et al.
Published: (2016-01-01)

Arterial elastic properties and central aortic pressure in patients with ankylosing spondylitis
by: T. A. Aksenova, et al.
Published: (2019-12-01)

Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
by: Yi Chen, et al.
Published: (2021-04-01)

Relation between postmenopausal osteoporosis and coronary and peripheral arterial disease
by: Mahmoud Shokry, et al.
Published: (2012-09-01)

Comparison of the Effects of Strontium Ranelate and Raloxiphene on Bone Mineral Density in Postmenopausal Osteoporosis - Original Investigation
by: Figen Yılmaz, et al.
Published: (2009-04-01)

The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review
by: Jie Xu, et al.
Published: (2023-07-01)

Arterial stiffness, vascular calcification and osteoporosis — common mechanisms of interaction (literature review)
by: O.I. Nishkumay, et al.
Published: (2022-06-01)

IMMUNOPATHOGENETIC MECHANISMS OF PERIODONTAL DISEASE AND POSTMENOPAUSAL OSTEOPOROSIS
by: Nadica Đorđević, et al.
Published: (2012-01-01)

Vitamin D Boosts Alendronate Tail Effect on Bone Mineral Density in Postmenopausal Women with Osteoporosis
by: Antonino Catalano, et al.
Published: (2021-05-01)

The Effect of Alendronate and Calcitonin Treatments on Bone Mineral Density and Quality of Life in Women With Postmenopausal Osteoporosis
by: F. Taşçıoğlu, et al.
Published: (2002-06-01)

Mineral bone density association with estrogen alpha receptor gene (ESRa) polymorphisms at postmenopausal osteoporosis
by: M Y Krylov, et al.
Published: (2005-02-01)

Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis
by: Filippo Migliorini, et al.
Published: (2021-08-01)

Association of Severity of Coronary Lesions with Bone Mineral Density in Postmenopausal Women
by: Rui Xu, et al.

ASSOCIATION OF INTERLEUKIN-1β GENE POLYMORPHISM WITH POSTMENOPAUSAL OSTEOPOROSIS IN WOMEN IN THE RUSSIAN POPULATION
by: M. Yu. Krylov, et al.
Published: (2015-10-01)

Association Between Serum Ferritin Levels and Low Bone Mineral Density in Postmenopausal Osteoporosis Women
by: Lama ALjeshi, et al.
Published: (2020-06-01)

Roles of Altered Macrophages and Cytokines: Implications for Pathological Mechanisms of Postmenopausal Osteoporosis, Rheumatoid Arthritis, and Alzheimer’s Disease
by: Yunteng Xu, et al.
Published: (2022-06-01)

The Effects of Risedronate Therapy Combined With Vitamin D and Calcium on Biochemical Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporosis
by: Hüsniye Koç, et al.
Published: (2004-12-01)

Cytokines, insulin resistance and arterial wall stiffness in assessing the course of non-alcoholic fatty liver disease
by: Yu. M. Stepanov, et al.
Published: (2022-06-01)

The Association of Intraocular Pressure with Vitamin D Levels and Bone Mineral Density in Postmenopausal Osteoporosis
by: Mehmet Uçar, et al.
Published: (2015-04-01)

Measurement of Bone Mineral Density in Diagnosis of Osteoporosis
by: Seher Kocaoğlu, et al.
Published: (2003-12-01)

Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis
by: Fatemeh Khanizadeh, et al.

Assessment of the Relationship Between Depression and Bone Mineral Density and Quality of Life in Patients with Postmenopausal Osteoporosis
by: Halil Koyuncu, et al.
Published: (2003-09-01)

INFLUENCE OF ANTIHYPERTENSIVE DRUGS ON ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION
by: N. V. Egorkina, et al.
Published: (2016-01-01)

Effect of Vitamin K and Alendronate Combination Treatment on Bone Mineral Density of Postmenopausal Osteoporosis Patients: A Pilot Study
by: Mohammad Hassan Jokar, et al.
Published: (2016-01-01)

Relationship between Two Panoramic Radiography Indices and Bone Mineral Density of Postmenopausal Women with Osteopenia and Osteoporosis
by: Nader Navabi, et al.
Published: (2018-09-01)

Impact of Risedronate on Bone Mineral Density and Quality of Life in Postmenopausal Women with Osteoporosis: The Results of 1-Year Follow up
by: Ercan Madenci, et al.
Published: (2003-06-01)

Mineral Density and Quantity of Bone, Parameters of Body Composition in Postmenopausal Women
by: O. Ivanyk
Published: (2016-04-01)

Clinical features of coronary heart disease in postmenopausal women, depending on the degree of bone mineral density loss
by: N. S. Mykhailovskaya, et al.
Published: (2015-08-01)

Associations of polymorphisms in the gene promoters of cytokines and matrix metalloproteinases with bone mineral density in postmenopausal type 2 diabetic women
by: Olga N. Fazullina, et al.
Published: (2018-03-01)